Crossmark

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s00280-015-2850-4

Published Online: 2015-09-14

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bendell, Johanna C.

Rosen, Lee S.

Mayer, Robert J.

Goldman, Jonathan W.

Infante, Jeffrey R.

Benedetti, Fabio

Lin, Donghu

Mizuguchi, Hirokazu

Zergebel, Christopher

Patel, Manish R.
License Information

License valid from 2015-09-14